Covered recipient · General Payments record
SEEMA K PATEL
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2019–2024
$420.58
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $310.59 | 13 |
| Education | $59.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $72.58 | 3 |
| Amgen Inc. | $67.24 | 3 |
| UCB, Inc. | $61.03 | 2 |
| Janssen Biotech, Inc. | $59.99 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $50.40 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.68 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.02 | 1 |
| Genentech USA, Inc. | $13.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.14 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104117092 | CMS |
| ABBVIE INC. | $18.71 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104117094 | CMS |
| ABBVIE INC. | $34.73 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104117096 | CMS |
| Amgen Inc. | $23.01 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116002077 | CMS |
| Amgen Inc. | $19.67 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116002091 | CMS |
| Amgen Inc. | $24.56 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116002085 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.68 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118186462 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.02 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101819111 | CMS |
| Genentech USA, Inc. | $13.64 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133109807 | CMS |
| Janssen Biotech, Inc. | $59.99 | 08/23/2024 | Education | Undisputed | 01/23/2026 | 1078802793 | CMS |
| Novartis Pharmaceuticals Corporation | $21.57 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087124900 | CMS |
| Novartis Pharmaceuticals Corporation | $28.83 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087124912 | CMS |
| UCB, Inc. | $27.47 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143491565 | CMS |
| UCB, Inc. | $33.56 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143491573 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2024
- Source files
- Dataset page · Bulk file · PY2019 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.